Anika Therapeutics, Inc. (ANIK) Stock buybacks 2016–2025
Anika Therapeutics, Inc. (ANIK) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$9.5MFY2025 · since FY2016: $25.0M → $9.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.5M | -13.1% |
| FY2024 | $10.9M | +118.3% |
| FY2023 | $5.0M | — |
| FY2022 | $0 | — |
| FY2021 | $0 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $30.0M | +0.0% |
| FY2018 | $30.0M | — |
| FY2016 | $25.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIK financial trends
ANIK RevenueANIK Net incomeANIK Net marginANIK Gross profitANIK Gross marginANIK Operating incomeANIK Operating marginANIK Operating cash flowANIK Free cash flowANIK Capital expendituresANIK Return on equityANIK Dividends paidANIK Total assetsANIK Total liabilitiesANIK Shareholders’ equityANIK overview →